Both generic Lexapro and brand-name Lexapro contain the same active ingredient: escitalopram oxalate. This is the key component responsible for the medication’s antidepressant effects. The FDA requires generic medications to contain the same amount of active ingredient as the brand-name drug, and to be bioequivalent. Bioequivalence means the generic drug is absorbed and utilized by the body in a similar way to the brand-name version.
Bioequivalence Studies and FDA Approval
Before a generic drug gains FDA approval, rigorous testing, including bioequivalence studies, verifies its similarity to the brand-name product. These studies compare the rate and extent of absorption of the active ingredient in both formulations. Passing these studies demonstrates comparable therapeutic effects, ensuring that the generic offers the same clinical benefit. Therefore, if a patient responds well to brand-name Lexapro, they can generally expect similar results from the generic version, containing the same escitalopram oxalate.
Inactive Ingredients and Potential Differences
While the active ingredient is identical, minor variations may exist in inactive ingredients. These are substances added to help with manufacturing, stability, or absorption. These differences are typically insignificant and unlikely to affect the drug’s efficacy. However, individual sensitivities to these inactive components might exist. If a patient experiences issues with a generic formulation, consulting their doctor to discuss potential alternatives is advisable.
